Developing a SARS-CoV-2 main protease binding prediction random forest model for drug repurposing for COVID-19 treatment

Abstract

The coronavirus disease 2019 (COVID-19) global pandemic resulted in millions of people becoming infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus and close to seven million deaths worldwide. It is essential to further explore and design effective COVID-19 treatment drugs that target the main protease of SARS-CoV-2, a major target for COVID-19 drugs. In this study, machine learning was applied for predicting the SARS-CoV-2 main protease binding of Food and Drug Administration (FDA)-approved drugs to assist in the identification of potential repurposing candidates for COVID-19 treatment. Ligands bound to the SARS-CoV-2 main protease in the Protein Data Bank and compounds experimentally tested in SARS-CoV-2 main protease binding assays in the literature were curated. These chemicals were divided into training (516 chemicals) and testing (360 chemicals) data sets. To identify SARS-CoV-2 main protease binders as potential candidates for repurposing to treat COVID-19, 1188 FDA-approved drugs from the Liver Toxicity Knowledge Base were obtained. A random forest algorithm was used for constructing predictive models based on molecular descriptors calculated using Mold2 software. Model performance was evaluated using 100 iterations of fivefold cross-validations which resulted in 78.8% balanced accuracy. The random forest model that was constructed from the whole training dataset was used to predict SARS-CoV-2 main protease binding on the testing set and the FDA-approved drugs. Model applicability domain and prediction confidence on drugs predicted as the main protease binders discovered 10 FDA-approved drugs as potential candidates for repurposing to treat COVID-19. Our results demonstrate that machine learning is an efficient method for drug repurposing and, thus, may accelerate drug development targeting SARS-CoV-2.

BERT-based language model for accurate drug adverse event extraction from social media: implementation, evaluation, and contributions to pharmacovigilance practices

“…Machine learning techniques have found widespread application in numerous fields for processing structured data (21)(22)(23)(24)(25)(26)(27)(28)(29)(30)(31)(32)(33)(34). However, when dealing with unstructured data, a unique set of methodologies is required due to the inherent nature of this data type (35)(36)(37)(38)(39).…”

Integrating artificial intelligence with bioinformatics promotes public health

“…Central to this strategy is the targeting of the SARS-CoV-2 Main Protease (Mpro), a key enzyme essential for viral replication. Liu et al 7 report the development and validation of a novel Random Forest machine learning model designed to predict the binding affinity of various small molecules to the SARS-CoV-2 Mpro. They constructed the predictive model using a comprehensive dataset of known Mpro-binding ligands, encompassing a diverse set of chemical compounds.…”